🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New in ESMO Open: Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- #MetastaticBreastCancer in the US real-world setting. 🔓pubmed.ncbi.nlm.nih.gov/39754979/ ✍️Hope Rugo Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 G Curigliano MD PhD @lynn_mcroy Adam Brufsky #BreastCancer #MBC

#DatoDxd was approved on 1/17/25 for HR+ mBC in endocrine resistant settings. But recent update with no OS!!!! This slide shared by Sara Tolaney does an excellent job showing data across different ADCs in this space. #bcsm #OncTwitter #MedTwitter

Congrats Dr. Fernando Barroso Duarte on the CIBMTR Distinguished Service Award! Dr. Duarte received a standing ovation and also shared a poem. #Tandem25 ASTCT

Regimen may become new standard for relapsed/refractory diffuse large B-cell lymphoma healio.com/news/hematolog… “We expected the clinical outcomes to be good but were surprised about how good they were,” said Joshua Brody, MD Icahn School of Medicine at Mount Sinai

🔥off the press: Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Annals of Oncology doi.org/10.1016/j.anno… 👉get the lastest update on HCC management 👉Multiple options > MDT is key ESMO - Eur. Oncology EASL Education ILCA #livertwitter

Neoadjuvant mFOLFOX With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer Annals of Oncology doi.org/10.1200/JCO-24… 🔎10-yr Follow-Up of FOWARC trial 🧐neoadjuvant mFOLFOX6 is a therapeutic option in LARC

Here’s the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (February 18th-23rd, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

Excited to present my poster at #NCCN2025 Grateful for the opportunity to contribute to cancer research!

A very Insightful session on multiple myeloma with Shaji Kumar from Mayo Clinic! Grateful for the expert guidance on latest advancements and treatment approaches. #HemeOnc #MedicalEducation #MultipleMyeloma” #NCCN2025

🚨 Big moves in #LungCancer at #ASCO25! 🚨 🔥 ADCs, KRASG12Ci and TKIs! 🧬 NeoADAURA: Neoadjuvant Osimertinib in EGFRm 💥 CheckMate 816 OS update 💉 Tarlatamab reshaping 2L SCLC 💡 Biomarkers, ctDNA, CAR-T, BiTEs! Excited for #ASCO25! 🫁✨ Full list 👇

Venetoclax plus 3+7 for newly diagnosed acute myeloid leukemia: results of a phase 1b study ashpublications.org/blood/article/… Ven given for 8, 11 and 14 days with 3+7. DNR at 90 mg/m2 in < 60 yrs. 58% with intermediate risk AML, 26.5% adverse risk. NPM1m 38%. cCR > 80%. NS

A perfect way to kick off #ASCO25 with the IMG session This initiative was started by the wonderful Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc following an impactful publication by Ayesha Butt, MD OncoAlert

Just had the pleasure of meeting Dr. Estela Rodriguez after their inspiring session at #ASCO25! Grateful for the insights and the opportunity to learn from such leaders in Hematology-Oncology. 🌟📚 #ASCOIMG #FellowshipJourney #HemOnc The ASCO Post Hem-Onc Fellows Network ASCO

#ASCO25 IMG CoP was one of a kind! Nazli Dizman Ziad Bakouny, MD, MSc & doctors from all over the 🌏 unpacked their paths and personal experience —J-1 → O-1 → EB1 🛂, years of re-training 🩺, learning new cultures, languages, etc… Mentorship tracks and opportunities, workshops, and the

#ASCO25 🎉 Congratulations to Nazli Dizman MD Anderson Cancer Center for her Healio NextGen Disruptor Award ASCO TECAG #IMGOnc

🔔Make sure to check our study!! ASCO #ASCO25 ⭐️#HighFiber (HF) #diet to modulate microbiome and outcomes in #immunotherapy in #Melanoma ✅ORR: ⬆️HF 77% Cntrl 29% ✅No significant GI related or Immune related AEs with HF diet ✅Cutaneous adverse events⬇️ w HF ✅ impressive EFS

Beautiful click 📷 #ASCO25 Cristiane D Bergerot - you're amazing!! #PalloncCoP #Pallonc

Houssein Safa, MD Hi Everyone! I’m Amara Sofia, IM resident. AAMC ID : 15375057 Excited to apply for #hemeOnc #fellowship this cycle! Grateful for every one who shaped this journey. 🩸✨ #Hemonc #MedTwitter #Match2026 #fellowshipmatch #Oncology #hematology #fellowship2026